Trials / Completed
CompletedNCT00263133
Modulation of Visually Evoked Potentials by an Antidepressant
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (planned)
- Sponsor
- University Hospital Freiburg · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
12 normal healthy controls will be treated with 50 mg sertraline once daily for three weeks. Early amplitudes of visually evoked potentials will be examined at day 0, 10 and 21 and statistically compared. This study aims to examine a putative modulation of synaptic transmission and plasticity by an antidepressant and is part of a series of studies in healthy individuals and depressed patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sertraline |
Timeline
- Start date
- 2005-12-01
- Completion
- 2006-01-01
- First posted
- 2005-12-07
- Last updated
- 2007-06-04
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00263133. Inclusion in this directory is not an endorsement.